Acadia Pharmaceuticals: Legal Overhang On Nuplazid Removed (NASDAQ:ACAD)

4 mins read
72 views

Why Acadia stock surged today

Shares of Acadia Pharmaceuticals (NASDAQ:ACAD) surged today after the U.S. District Court for the District of Delaware granted a summary judgment in the Nuplazid patent case against MSN Pharmaceuticals. This

Read the full article here

Leave a Reply

Your email address will not be published.

Previous Story

Biden hosts families of American hostages held by Hamas as he navigates first breaks with Netanyahu

Next Story

ChatGPT did not increase cheating in high schools, Stanford researchers find

Latest from News